anti-inflammatory (Innovation Pharmaceuticals)

N/A

Report date: 2025/01/26 16:28:52
NME

Base Information

Drug Nameanti-inflammatory (Innovation Pharmaceuticals)
Drug Alias Nameanti-inflammatory (Cellceutix)KM-278
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAsthmaOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInnovation Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAsthmaOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A